• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Hygiene and Health: 8 Pristine Questions

Slideshow

Sample: The hygiene hypothesis states that early exposure to germs reduces the immune system’s ability to resist infections in later years. True or false?

Recent reports and studies have focused on the relationships between hygiene and health, in particular, the hygiene hypothesis-what effects a sanitized environment may have on the development of the human immune system. Take this brief quiz to test your knowledge of the latest developments and research findings.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
ARS Pharma Submits Response to FDA Complete Response Letter for neffy (epinephrine nasal spray) / image credit word map anaphylaxis ©kalpis/stock.adobe.com

ARS Pharma Submits Response to FDA Complete Response Letter for neffy (epinephrine nasal spray)

April 3rd 2024
Article

Positive findings from a repeat dosing study of neffy under nasal allergen challenge conditions will support a potential PDUFA date of October 2, 2024, the company said.

Hepatitis C: What If You Do Not Treat?

Hepatitis C: What If You Do Not Treat?

April 18th 2017
Podcast

Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.

Neffy May be Safe, Effective for Treatment of Urticaria Flares: Daily Dose / image credit: ©New Africa/AdobeStock

Neffy May be Safe, Effective for Treatment of Urticaria Flares: Daily Dose

March 7th 2024
Article

Your daily dose of the clinical news you may have missed.

Needle-free Epinephrine Delivery: Perceptions of Physicians, Patients, and Caregivers / image credit: epipen injection: ©Rob Byron/stock.adobe.com

Needle-free Epinephrine Delivery: Perceptions of Physicians, Patients, and Caregivers

February 27th 2024
Article

AAAAI 2024. Needle phobia is just one of the barriers to not just using an epinephrine autoinjector but to carrying one at all, according to 2 sets of surveys findings.

New Data Suggest neffy May be Safe, Effective for Treatment of Urticaria Flares / Image credit: ©chomplearn 2001/AdobeStock

New Data Suggest neffy May be Safe, Effective for Treatment of Urticaria Flares

February 26th 2024
Article

AAAAI 2024. In patients with treatment-resistant chronic spontaneous urticaria, neffy 1 mg and 2 mg resulted in improvement in itch, hives, urticaria, and erythema scores 5 minutes after dosing.

Neffy Generates Favorable PK/PD Data Under Nasal Allergen Challenge in Repeat Dosing Study Requested by FDA / image credit pollen, allergy: ©jovan vitanovski/shutterstock.com

Neffy Generates Favorable PK/PD Data Under Nasal Allergen Challenge in Repeat Dosing Study Requested by FDA

February 26th 2024
Article

neffy (epinephrine nasal spray) delivered a PK and PD profile greater than or similar to that of IM epinephrine after extreme nasal challenge, reports ARS Pharmaceuticals.

© 2024 MJH Life Sciences

All rights reserved.